Some of the most amazing healing and regenerative tissue discovered to date resides exactly where our life begins; in the perinatal tissue that is donated and screened from health births. The science and product development is improving and evolving rapidly.
At the Center for Wellbeing, we use Mesenchymal Stem Cell Derived Biologics, because they garner the best results for our patients. They contain the highest concentration of "Day 0" mesenchymal stem cell messengers and other growth factors that signal your cells to activate your own self-healing healing mechanisms. We use other complementary therapies as well such as, PRP (platelet rich plasma from your own blood), Prolozone, Peptides and others to activate your body to heal.
These mesenchymal stem cell messengers and growth factors have three valuable properties:
To learn more and discover if this is for you, click the button below to schedule a phone consultation or an exam with our medical team.
Mesenchymal Stem Cell Messengers
Not all stem cells products are created equal. The Center for Wellbeing utilizes MSC derived biologics. These are the signals and healing messengers from the cells. There have three very important properties: they help reduce inflammation; modulate the immune system; and helps tissue to regenerate.
How Do They Work?
MSC derived messengers have an innate intelligence and activate the body’s own self-healing mechanisms. They seek out inflammation and degeneration. In other words, they give your body a boost of fresh, “day 0”, stem cell messengers to help with regeneration. Our stem cells age with us and we lose a significant percentage over time. That's why we don't recover as quickly as we did in our younger years.
Safe and Regulated
The stem cell derived biologics are procured and processed in the United States according to standards and regulations established by the American Association of Tissue Banks (AATB), the United States Food & Drug Administration (FDA). All local donors. Donor ethics and non-reactive FDA approved serological screening.
Amniotic fluid allografts have been FDA registered and processed in accordance with 21 CFR 1271 for “Homologous Use” to cover and protect tissues by providing cushioning, lubrication, and support.